Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Vi Polysaccharide Typhoid Vaccine

Approval Number

国药准字S10960013

Company成都生物制品研究所有限责任公司

Registration Date

November 18, 2020

Previous Approval Numbers

国药准字S10960013

Drug Information

Generic Name

伤寒Vi多糖疫苗

Dosage Form

注射剂(注射液)

Strength

每支1ml(2次人用剂量)。每1次人用剂量0.5ml,含伤寒Vi多糖应不低于30μg。

Drug Type

生物制品

Registration Date

November 18, 2020

Company Information

Applicant Company

Company Name成都生物制品研究所有限责任公司

Company Address

四川省成都市锦江区锦华路三段379号

Manufacturing Company

Company Name成都生物制品研究所有限责任公司

Company Address

四川省成都市锦江区锦华路三段379号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy